Status | Study |
Recruiting |
Study Name: Study of Suberoylanilide Hydroxamic Acid (SAHA) With Temsirolimus in Children With Diffuse Intrinsic Pontine Glioma (DIPG) Condition: Diffuse Intrinsic Pontine Glioma Date: 2015-04-15 Interventions: Drug: Vorinostat |
Recruiting |
Study Name: Molecular Profiling for Individualized Treatment Plan for DIPG Condition: Diffuse Intrinsic Pontine Glioma (DIPG) Date: 2014-10-21 Interventions: Other: Specialized tumor board recommendation |
Recruiting |
Study Name: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication Condition: Diffuse Intrinsic Pontine Glioma Date: 2014-08-29 Interventions: Drug: Erlotinib Drug: Everolimus |
Recruiting |
Study Name: WEE1 Inhibitor AZD1775 and Local Radiation Therapy in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas Condition: Diffuse Intrinsic Pontine Glioma Untreated Childhood Anaplastic Date: 2013-08-12 Interventions: Other: Laboratory Biomarker Analysis |
Completed |
Study Name: Palliative Re-irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG) in Children Condition: Pediatric Malignant Brain Tumor -Diffuse Intrinsic Pontine Glioma Date: 2013-01-13 Interventions: Radiation: Palliative re-irradiation for progressive DIPG in children |
Suspended |
Study Name: Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG). Condition: Diffuse Intrinsic Pontine Glioma (DIPG) Date: 2012-09-10 Interventions: Drug: Melphalan hydrochloride Drug administered intra-arte |
Terminated |
Study Name: Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents Condition: Gliomas Date: 2012-01-11 Interventions: Drug: Cilengitide Cilengitide |
Active, not recruiting |
Study Name: Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma Condition: Diffuse Intrinsic Pontine Glioma Date: 2011-07-19 Interventions: Biological: Tumor Lysate Vaccine |
Completed |
Study Name: PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma Condition: Diffuse Intrinsic Pontine Glioma Progressive or Refractory High Date: 2011-07-11 Interventions: Drug: Crenolanib Crenolanib orally administered as whole or crushed tablets once per day with concurrent |
Active, not recruiting |
Study Name: Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas Condition: Diffuse Intrinsic Pontine Glioma Anaplastic Astrocytoma Date: 2010-10-15 Interventions: Drug: Lenalidomide |